A few genes, such as IDO1, IL4, and IL13, which showed higher amplification or deletion frequency in the high PAN2RS subgroup than in the low PAN2RS subgroup, might play a central role in the prognosis of AML patients. This evidence concerns the gene IL13 and acute myeloid leukemia.